
Yeast-based antibody discovery and engineering platform for developable therapeutics
Adimab offers yeast-based antibody discovery and optimization services emphasizing high-affinity binders and engineering for pharma partners. It leverages display technologies for rapid affinity maturation across diverse targets. Compared to Abalone Bio, Adimab centers on binding and developability rather than direct functional activity screening at 100M scale. Its yeast platform shares some similarities but does not link survival to GPCR activation or generate activity datasets for AI design of agonists. Abalone Bio's FAST approach provides an edge for activating challenging receptors where Adimab's methods may require extensive secondary assays.
Free